| Literature DB >> 33106190 |
Francesco Vladimiro Segala1, Rita Murri2,3, Eleonora Taddei2,3, Francesca Giovannenze2, Pierluigi Del Vecchio2, Emanuela Birocchi2, Francesco Taccari2, Roberto Cauda2,3, Massimo Fantoni2,3.
Abstract
OBJECTIVES: Surgical antibiotic prophylaxis (SAP) represents a major indication of antibiotic consumption worldwide. The present study aims to report the results of an enabling, long-term AMS intervention conducted between 2013 and 2019 on an Italian University Hospital performing more than 40.000 surgical interventions per year.Entities:
Keywords: Antibiotic resistance; Antibiotic stewardship; Surgical prophylaxis; Surgical-site infection
Year: 2020 PMID: 33106190 PMCID: PMC7586646 DOI: 10.1186/s13756-020-00814-6
Source DB: PubMed Journal: Antimicrob Resist Infect Control ISSN: 2047-2994 Impact factor: 4.887
Demographic variables and patients characteristics before and after intervention
| Variable | Total sample | Baseline | Post-intervention |
|---|---|---|---|
| Cases, n | 789 (100) | 407 (51.6) | 382 (48.4) |
| Age, mean (SD) year | 56.7 (17.8) | 52.5 (18.5) | 61.2 (16) |
| Females, n (%) | 465 (58.9) | 237 (58.3) | 229 (60.1) |
| Reported allergy to beta-lactams, n (%) | 15 (1.9) | 6 (1.4) | 9 (2.3) |
| Surgical procedure, n (%) | |||
| Cardiac surgery | 61 (7.7) | 14 (3.4) | 47 (12.3) |
| Digestive surgery | 95 (12.0) | 35 (8.6) | 60 (15.7) |
| Endocrine surgery | 78 (9.9) | 61 (15.0) | 17 (4.5) |
| Vertebral surgery | 8 (1) | 5 (1.2) | 3 (8) |
| Hepato–pancreato–biliary surgery | 19 (2.4) | 15 (3.7) | 4 (1) |
| Gynecologic surgery | 128 (16.2) | 74 (18.2) | 54 (14.1) |
| Neurosurgery | 81 (10.3) | 28 (6.9) | 53 (13.9) |
| Ear–nose–throat surgery | 104 (13.2) | 57 (14.0) | 47 (12.3) |
| Orthopedic surgery | 116 (14.7) | 72 (17.7) | 44 (11.5) |
| Urology | 99 (12.5) | 46 (11.3) | 53 (13.9) |
| Surgical wound class, n (%) | |||
| Clean | 488 (61.9) | 242 (59.5) | 246 (64.4) |
| Clean-contaminated | 197 (25) | 140 (34.4) | 57 (14.9) |
| Contaminated | 85 (10.8) | 21 (5.2) | 64 (16.8) |
| Dirty | 19 (2.5) | 4 (1) | 15 (3.9) |
SAP appropriateness
| Variable | Total sample | 2013 | 2019 | |
|---|---|---|---|---|
| Overall appropriatenessa, n (%) | 370 (46,9) | 149 (36,6) | 221 (57,9) | < 0,0001 |
| Appropriateness in | 594 (75,3) | 238 (58,5) | 356 (93,2) | < 0,0001 |
| Appropriateness in | 546 (69,2) | 238 (58,5) | 308 (80,6) | < 0,0001 |
| Appropriateness in | 749 (94,9) | 376 (92,4) | 373 (97,6) | = 0,001 |
| Appropriateness in | 595 (75,4) | 289 (71) | 306 (80,1) | = 0,002 |
| Multi-dimensional inappropriatenessf | ||||
| within total cases, % | 28,1 (221/789) | 44,7 (182/407) | 10,2 (39/382) | < 0,0001 |
| within inappropriate cases, % | 52,7 (221/419) | 70,5 (182/258) | 24,2 (39/161) | |
a SAP prescriptions fully adherent to local guidelines
b SAP administered only if indicated in local guidelines or not administered if not recommended for the specific surgical
procedure
c Correct choice and dosing of the antimicrobial agent, including repeated doses in cases of procedures lasting > 4 h
d SAP administered within 120 min from the incision
e SAP discontinued within 24 h from surgery, or within 48 h from open-heart surgery
f SAP prescriptions non adherent to local guidelines for ≥2 dimensions
Fig. 1Total number of inappropriate cases per dimension at baseline and post-interventional survey